Health Canada Grants MADM™ Medical Device License
TORONTO, February 9, 2018 (Newswire.com) - Thornhill Medical has received notification from Health Canada that the MADM™, Mobile Anesthesia Delivery Module has received approval for its Medical Device License.
About MADM™
We are extremely pleased to provide a new breakthrough in anesthesia delivery. Our MADM™ device can be added to any ventilator to create a portable anesthesia machine. Adding Health Canada approval to our FDA clearance now allows us to provide this groundbreaking technology to health-care providers throughout North America.
Kipton Lade, President and CEO, Thornhill Medical
MADM™ is the first:
· Digital anesthetic vaporizer
· In-circuit anesthesia delivery device
· Versatile anesthetic delivery:
o Can be added to any anesthetic machine.
o The same vaporizer delivers Isoflurane or Sevoflurane.
o The rate of induction of inhalational anesthesia independent of fresh gas flow.
o Can be added to any ventilator — even flow through ventilators or self-inflating bags to turn them into anesthetic delivery machines.
o Can be used to delivery inhalation anesthesia in the operating room, intensive care unit, emergency department and even in the field during military operations or disasters.
o Can be used with an anesthetic reflector to improve the efficiency of anesthetic delivery by an order of magnitude.
"We are extremely pleased to provide a new breakthrough in anesthesia delivery. Our MADM™ device can be added to any ventilator to create a portable anesthesia machine. Adding Health Canada approval to our FDA clearance now allows us to provide this groundbreaking technology to health-care providers throughout North America," stated Kipton Lade, President, and CEO of Thornhill Medical.
About Thornhill Medical
The MADM™ Mobile Anesthesia Delivery Module is designed and manufactured at Thornhill Medical’s ISO 13485-certified facility in Toronto, Ontario, Canada. The company develops and manufactures innovative healthcare devices. The founder, Dr. Joseph Fisher is a specialist in Internal Medicine and Anesthesiology. He is also an active scientist in the fields of critical care medicine and cardiopulmonary and cerebrovascular physiology with more than 170 peer-reviewed publications and 40 patents. The University Health Network spun off Thornhill Medical in 2003 as a for-profit company tasked to capitalize on Dr. Fisher’s expertise and inventiveness to make novel treatments and diagnostics available to the public. Our full story can be found on our website - www.thornhillmedical.com.
Media Contact
Kipton Lade
President & CEO
Thornhill Medical
(416) 597-1325
klade@thornhillmedical.com
Source: Thornhill Medical
